Clinical Trial Update: A Trial Investigating Lu AG22515 in Adult Participants With Moderate-to-Severe Thyroid Eye Disease [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial investigating Lu AG22515 in adults with moderate-to-severe Thyroid Eye Disease; the study status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Eye Disease

Drugs mentioned

• Lu AG22515

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Thyroid Eye Disease | Phase 1 | Status: ACTIVE_NOT_RECRUITING